Orphazyme completes enrollment in phase 3 trial evaluating arimoclomol in amyotrophic lateral sclerosis
Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases announces that it has completed enrollment in its phase...
Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain
Cryoport, Inc and EVERSANA have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be...
Hilleman Laboratories licenses Oral Cholera Vaccine Hillchol to Bharat Biotech
Hilleman Laboratories, a global research and development organization focused on delivering high-impact and affordable vaccines, announced that it has entered into a collaboration with...
IBM KPMG Merck and Walmart to collaborate as part of FDA s program to evaluate the use of blockchain to protect pharmaceutical product integrity
IBM and Walmart announced that the companies have been selected by the US FDA to be included in a program in support of the...
Boehringer Ingelheim Gubra to develop anti-obesity peptide poly agonists
Boehringer Ingelheim and Gubra announce a second collaboration and license agreement for the development of novel poly-agonist peptides to treat obesity.
It will bring together...
Lantheus, NanoMab to offer novel biomarker to develop immuno-oncology therapies
Lantheus Holdings has collaborated with NanoMab Technology to provide a novel biomarker for clinical development and management of immuno-oncology therapies.
As part of strategic collaboration...
LYNPARZA delivers 72per ORR in phase 3 SOLO3 trial in advanced ovarian cancer
AstraZeneca and Merck presented full results from the Phase 3 SOLO3 trial which evaluated LYNPARZA, compared to chemotherapy, for the treatment of platinum-sensitive relapsed...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...